Clinical Research Division study details first successful use of expanded umbilical-cord blood units and potential for increased donor matches
Jan. 18, 2010
| By Dean Forbes
Fred Hutchinson Cancer Research Center's Dr. Colleen Delaney and fellow Clinical Research Division scientists have cleared a major technical hurdle to making umbilical cord blood transplants a more widely used method for treating leukemia and other blood cancers.
Clinical Research Division scientists join national consortium, bicoastal partnerships
Oct. 12, 2009
The National Heart, Lung and Blood Institute has awarded $16.7 million to Fred Hutchinson Cancer Research Center Drs. Irwin Bernstein and Beverly Torok-Storb of the Clinical Research Division, part of a $170 million effort for 18 teams of research scientists to develop the high-potential field of stem and progenitor cell tools and therapies.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.